Our results indicate that SFN may down-regulate DNA methyltransferases (DNMTs) resulting in de-methylation of the cyclin D2 promoter and de-repression of cyclin D2 expression, and suggest a novel mechanism behind SFN's growth inhibitory effects on prostate cancer cells. This evidence concerns the gene CCND2 and prostate cancer.